12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sun, 24 Aug 2025 18:44:15 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Server: cloudflare [5] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [6] => Vary: Accept-Encoding [7] => X-Powered-By: PHP/7.4.33 [8] => Cache-Control: no-cache, private [9] => X-Frame-Options: SAMEORIGIN [10] => X-Xss-Protection: 1; mode=block [11] => X-Content-Type-Options: nosniff [12] => Referrer-Policy: no-referrer-when-downgrade [13] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=4gSqTj5Xy8FjmlEdoBJ9G2591qc%2BQhmwdg7PaKK%2BaLLhtSm54ho0qsrnQ56ubdvqskXuAzyvamLb9%2BWRpStBsgEEB1%2BTLnwAE8%2FQ%2FNA%3D"}]} [14] => Cf-Cache-Status: DYNAMIC [15] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [16] => Server-Timing: cfEdge;dur=2,cfOrigin;dur=2 [17] => Set-Cookie: UpalLiveSession=eyJpdiI6ImNyb09vWTM1Z3p6c1wvdGQ5eFlLR0R3PT0iLCJ2YWx1ZSI6IlF1QU9zWVN4dVdZZmZhcDRYQ0ZuRWNvWXN5M1JxWlA5WUVqV1ZScVAwbWpIYmNVSDVCcVQ4dTBaRnlFb2p0cmlrT3I3aXVNNzJSdDBRTlk1Nm1NVld3PT0iLCJtYWMiOiJkOTRiZjUzZTUxY2Q1YzZkZmNjYzc0N2FhM2I3NTcxNDQ0OTJmN2E1MjljNzZhNWIwOWIxODc1MmRhZTQ3ZGI1In0%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Wed, 23 Aug 2028 18:19:23 GMT [18] => CF-RAY: 9744fffd2dafd433-KUL [19] => alt-svc: h3=":443"; ma=86400 ) 789

世界卫生组织会议的联席主持人周三表示，中国科学家正在测试两种针对2019年新型冠状病毒（COVID-19）的抗病毒药物，初步临床试验结果将在几周后公布。

根据路透社报道，前世卫组织病毒学家玛丽保罗基尼（Marie-Paule Kieny）博士与其他人共同主持了在日内瓦举行的为期2天的闭门研究论坛，有300多名科学家和研究人员参加，其中一些中国内地和台湾的科学家通过视讯参与了会议。

她周三在新闻发布会上透露，很多病人已经服用了抗病毒药物利托那韦（ritonavir）和洛匹那韦（lopinavir）联合干扰素，但是她没有确切的数据。